Brands
Discover
Events
Newsletter
More

Follow Us

twitterfacebookinstagramyoutube
ADVERTISEMENT
Advertise with us
Resolve Therapeutics

Resolve Therapeutics is focused on developing a novel approach to the treatment of Systemic Lupus Erythematosus (SLE).

linkedin icon
ADVERTISEMENT
Advertise with us
Basic Information
Resolve Therapeutics is a biotechnology company developing an exciting new biologic compound for the treatment of lupus that inhibits a key upstream step in the interferon cascade. The company is based on technology and compounds exclusively licensed from the University of Washington. The company will develop these compounds through early clinical testing and partner with a pharmaceutical company for late stage clinical development and commercialization.
Legal Name
:
Resolve Therapeutics, LLC
Headquarters
:
Kirkland, Washingston, United States of America
Founding Date
:
2010
No. of Employees
:
11 to 20
Core Team
:
1.  
James Posada
Co-Founder and CEO
Linkedin Icon
ADVERTISEMENT
Advertise with us
ADVERTISEMENT
Advertise with us
Funding
Investors
:
1.  
New Science Ventures
Linkedin Icon
Advertise with Us
ADVERTISEMENT